281 related articles for article (PubMed ID: 24464947)
1. Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers.
Reddick WE; Taghipour DJ; Glass JO; Ashford J; Xiong X; Wu S; Bonner M; Khan RB; Conklin HM
Pediatr Blood Cancer; 2014 Jun; 61(6):1074-9. PubMed ID: 24464947
[TBL] [Abstract][Full Text] [Related]
2. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia.
Reddick WE; Shan ZY; Glass JO; Helton S; Xiong X; Wu S; Bonner MJ; Howard SC; Christensen R; Khan RB; Pui CH; Mulhern RK
Cancer; 2006 Feb; 106(4):941-9. PubMed ID: 16411228
[TBL] [Abstract][Full Text] [Related]
3. Modeling children's white matter volume intelligence and academic achievement in response to CNS-directed therapy.
Annett RD; Annett GE
Pediatr Blood Cancer; 2014 Jun; 61(6):960-1. PubMed ID: 24623681
[No Abstract] [Full Text] [Related]
4. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
5. CNS prophylaxis of childhood leukemia: what are the long-term neurological, neuropsychological, and behavioral effects?
Stehbens JA; Kaleita TA; Noll RB; MacLean WE; O'Brien RT; Waskerwitz MJ; Hammond GD
Neuropsychol Rev; 1991 Jun; 2(2):147-77. PubMed ID: 1844707
[TBL] [Abstract][Full Text] [Related]
6. Impaired brain metabolism and neurocognitive function in childhood leukemia survivors despite complete hormone supplementation in adulthood.
Follin C; Erfurth EM; Johansson A; Lätt J; Sundgren PC; Österberg K; Spulber G; Mannfolk P; Björkman-Burtscher IM
Psychoneuroendocrinology; 2016 Nov; 73():157-165. PubMed ID: 27498291
[TBL] [Abstract][Full Text] [Related]
7. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
[TBL] [Abstract][Full Text] [Related]
9. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological sequelae of central nervous system prophylaxis in survivors of childhood acute lymphoblastic leukemia.
Said JA; Waters BG; Cousens P; Stevens MM
J Consult Clin Psychol; 1989 Apr; 57(2):251-6. PubMed ID: 2708613
[TBL] [Abstract][Full Text] [Related]
11. Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia.
Fellah S; Cheung YT; Scoggins MA; Zou P; Sabin ND; Pui CH; Robison LL; Hudson MM; Ogg RJ; Krull KR
J Natl Cancer Inst; 2019 Feb; 111(2):201-209. PubMed ID: 29790971
[TBL] [Abstract][Full Text] [Related]
12. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
Mulhern RK; Khan RB; Kaplan S; Helton S; Christensen R; Bonner M; Brown R; Xiong X; Wu S; Gururangan S; Reddick WE
J Clin Oncol; 2004 Dec; 22(23):4795-803. PubMed ID: 15570081
[TBL] [Abstract][Full Text] [Related]
13. Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia.
Raymond-Speden E; Tripp G; Lawrence B; Holdaway D
J Pediatr Psychol; 2000 Mar; 25(2):59-68. PubMed ID: 10820944
[TBL] [Abstract][Full Text] [Related]
14. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
Kähkönen M; Metsähonkala L; Minn H; Utriainen T; Korhonen T; Norvasuo-Heilä MK; Harila-Saari A; Aärimaa T; Suhonen-Polvi H; Ruotsalainen U; Solin O; Salmi TT
Cancer; 2000 Feb; 88(3):693-700. PubMed ID: 10649265
[TBL] [Abstract][Full Text] [Related]
15. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
16. Slower processing speed after treatment for pediatric brain tumor and acute lymphoblastic leukemia.
Kahalley LS; Conklin HM; Tyc VL; Hudson MM; Wilson SJ; Wu S; Xiong X; Hinds PS
Psychooncology; 2013 Sep; 22(9):1979-86. PubMed ID: 23447439
[TBL] [Abstract][Full Text] [Related]
17. Cognitive effects of cranial irradiation in leukaemia: a survey and meta-analysis.
Cousens P; Waters B; Said J; Stevens M
J Child Psychol Psychiatry; 1988 Nov; 29(6):839-52. PubMed ID: 3069852
[TBL] [Abstract][Full Text] [Related]
18. Late neurocognitive sequelae in survivors of brain tumours in childhood.
Mulhern RK; Merchant TE; Gajjar A; Reddick WE; Kun LE
Lancet Oncol; 2004 Jul; 5(7):399-408. PubMed ID: 15231246
[TBL] [Abstract][Full Text] [Related]
19. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia.
Cole PD; Kamen BA
Ment Retard Dev Disabil Res Rev; 2006; 12(3):174-83. PubMed ID: 17061283
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Attention Problems on Psychosocial Functioning in Childhood Brain Tumor Survivors: A 2-Year Postcraniospinal Irradiation Follow-up.
Oh Y; Seo H; Sung KW; Joung YS
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e46-e53. PubMed ID: 28099397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
